Study details
Enrolling now
Imaging of Solid Tumors Using 18F-TRX
Rahul Aggarwal
NCT IDNCT06942104ClinicalTrials.gov data as of Apr 2026
Phase
Phase 1
Target enrollment
56
Study length
about 1.2 years
Ages
18+
Locations
1 site in CA
What this study is about
This trial is testing the safety and effectiveness of a treatment called 18F-TRX for detecting tumors in patients with solid tumors. 18F-TRX is an imaging tracer used to visualize tumors using PET scans, which target unstable iron levels within tissues.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take 18F-TRX
- 2.Undergo Blood Specimen Collection
- 3.Undergo Positron Emission Tomography (PET)/Computerized tomography (CT)
- +1 more
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Standard
How treatment is administered
Treatment Assignment
All receive treatment
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Endpoints
Primary: Proportion of participants with treatment-emergent adverse events
Procedures
imaging, biopsy
Body systems
Oncology